ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) is a clinical-stage biopharmaceutical company that discovers and develops therapies ...
In other news, earlier in its Q3 2025 earnings report, UniQure detailed promising clinical data for its lead gene therapy ...
Aurora Innovation Inc. (NASDAQ: AUR) is one of the stocks that will double in 2026. On December 9, Itay Michaeli from TD ...
Evolent Health Inc. (NYSE: EVH) is one of the stocks that will double in 2026. On November 21, Citi lowered the firm’s price ...
Earlier in its Q3 2025 earnings report, Evolus achieved global net revenue of $69 million, which marked a 13% increase ...
In its Q3 2025 earnings report, Bitfarms highlighted significant progress in transitioning from Bitcoin mining to becoming a ...
In Q3 2025, Gogo announced that the company shipped a record 437 Air-to-Ground/ATG units in the quarter, signaling strong ...
Solid Biosciences Inc. (NASDAQ:SLDB) develops therapies for neuromuscular and cardiac diseases in the US. In addition, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback